Hosted on MSN19h
Regeneron CEO: We have 40 drugs in development
In an interview on CNBC’s Mad Money, Len Schleifer said Regeneron (REGN) currently has 40 drugs in development representing billions in potential ...
Cramer's Lightning Round: Super Micro Computer is a sell
Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...
Cramer's Lightning Round: AeroVironment is a buy
Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...
Benzinga.com6d
Jim Cramer: Lemonade Is 'Up Too Much,' This Health Care Stock Can Go Lower
On CNBC's “Mad Money Lightning Round,” Jim Cramer weighed in on stocks brought up by viewers, highlighting risks and opportunities in the market. Lemonade, Inc. LMND has climbed significantly ...